0000784199-15-000055.txt : 20150220
0000784199-15-000055.hdr.sgml : 20150220
20150220165527
ACCESSION NUMBER: 0000784199-15-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150219
FILED AS OF DATE: 20150220
DATE AS OF CHANGE: 20150220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRYOLIFE INC
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 592417093
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
STREET 2: STE 142
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
STREET 2: STE 142
CITY: KENNESAW
STATE: GA
ZIP: 30144
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mackin James P
CENTRAL INDEX KEY: 0001408470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 15636430
MAIL ADDRESS:
STREET 1: CRYOLIFE, INC.
STREET 2: 1655 ROBERTS BLVD, NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
4
1
rivet-form4.xml
PRIMARY DOCUMENT
X0306
4
2015-02-19
0000784199
CRYOLIFE INC
CRY
0001408470
Mackin James P
CRYOLIFE, INC.
1655 ROBERTS BLVD, NW
KENNESAW
GA
30144
0
1
0
0
President & CEO
Common Stock
2015-02-19
4
A
0
30832
11.00
A
280832
D
Stock Option (Right to Buy)
11.00
2015-02-19
4
A
0
85105
0
A
2016-02-19
2022-02-19
Common Stock
85105
85105
D
Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date (February 19, 2015).
/s/ D. Ashley Lee, Attorney-in-fact
2015-02-20
EX-24
2
poamackin.txt
Exhibit 24
CONFIRMING STATEMENT
This Statement confirms that the undersigned has authorized and designated
the Chief Financial Officer, Secretary, or the Assistant Secretary of
CryoLife, Inc. to execute and file on the undersigned's behalf all Forms 3,
4 and 5 (including any amendments thereto) that the undersigned may be
required to file with the U.S. Securities and Exchange commission as a
result of the undersigned's ownership of or transactions in securities of
CryoLife, Inc. The authority of the Chief Financial Officer, the
Secretary, or the Assistant Secretary of CryoLife, Inc. under this
Statement shall continue until the undersigned is no longer required to
file Forms 3, 4 and 5 with regard to the undersigned's ownership of or
transactions in securities of CryoLife, Inc., unless earlier revoked in
writing. The undersigned acknowledges that the Chief Financial Officer,
the Secretary, or the Assistant Secretary of CryoLife, Inc. is not assuming
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.
Dated as of September 2, 2014 /s/ James P. Mackin
James Patrick Mackin